StockData
Apollomics Inc. logo

Apollomics Inc. (APLM) stock

APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30
$16.84−1.00 (-5.61%)

Close on Nov 17, 2026Market cap $36.98MP/E –Yield –

Apollomics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2022 it was $976.00K.

Annual operating income

PeriodPeriod endValueChange
FY2022Dec 31, 2022$976.00K–

More Apollomics figures

See a number that looks wrong?